Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share it with others. That’s right. Send us your changes and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Epirus Biopharmaceuticals hired Vincent Aurentz as chief business officer. Previously, he headed HemoShear Therapeutics and, before that, an executive vice president at Merck KGgA. He was also an executive vice president at Quintiles.
Viamet Pharmaceuticals hired Volker Herrmann as chief commercial officer;
Insys Therapeutics says Michael Babich resigned as ceo and president;
Insys Therapeutics named John Kapoor to replace Babich as ceo and president;
Lupin named Fabrice Egros as president of its Asia Pacific and Japan region;
Astellas hired Peter Sandor as vp, head of oncology therapeutics in marketing strategy;
OticPharma hired Catherine Turkel as senior vp, clinical R&D and chief development officer;
Arog Pharmaceuticals hired Ada Braun as senior vice president of clinical development;
Biota Pharmaceuticals hired Mark Colonnese as exec vp and chief financial officer;
T2 Biosystems hired David Harding as chief commercial officer;
Abzena hired Campbell Bunce as senior vice president of scientific operations;
TWi Pharmaceuticals says Tina Guilder resigned as chief executive and president;
TWi Pharmaceuticals named Chih-Ming Chen as interim chief executive and president;